The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy Males – Beigene

⟵ Back to Search Results

The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy Males

Beigene Study ID

BGB-3111-112

ClinicalTrials.gov ID

NCT04470908

Study Overview

Sex: Male

Age: 18 Years to 65 Years (Adult, Older Adult)

No Study Documents

Study Overview

Sex: Male

Age: 18 Years to 65 Years (Adult, Older Adult)

No Study Documents